C12N 2760/18233
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/18233 (Use of viral protein as therapeutic agent other than vaccine) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 8
- Assignees
- 11
- Inventors
- 13
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- CD8-specific antibody constructs and compositions thereof7 Jul 2026US 12,674,180 B2Sana Biotechnology, Inc.
- CD8-specific antibody constructs and compositions thereof27 Dec 2022US 11,535,869 B2Sana Biotechnology, Inc.
- Peptides including a binding domain of the viral phosphoprotein (P) subunit to the viral RNA free nucleoprotein (N0)23 Apr 2019US 10,266,569 B2Centre National de le Recherche Scientifique (CNRS)
- Composition and methods for the inhibition of membrane fusion by paramyxoviruses14 Feb 2012US 8,114,410 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Compositions and methods for the inhibition of membrane fusion by paramyxoviruses23 Feb 2010US 7,666,431 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Cd8-specific antibody constructs and compositions thereof10 Sep 2026US 2026/0265780 A1Sana Biotechnology, Inc.
- Cd8-specific antibody constructs and compositions thereof17 Aug 2023US 2023/0257773 A1Sana Biotechnology, Inc.
- Cd8-specific antibody constructs and compositions thereof20 Oct 2022US 2022/0333134 A1Sana Biotechnology, Inc.
- Hendra and nipah virus g glycoprotein immunogenic compositions21 Mar 2019US 2019/0083604 A1Zoetis Services LLC
- Peptides including a binding domain of the viral phosphoprotein (p) subunit to the viral rna free nucleoprotein (n0)8 Jun 2017US 2017/0158741 A1Centre National de la Recherche Scientifique (CNRS)
Most cited
By later US patents